The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Gain on contribution to equity method investment | - | 65 | - | - |
| Impairment of equity securities | - | 0 | - | - |
| Change in fair value of financial instruments carried at fair value | - | 8,179 | - | - |
| Net loss | -32,485 | -20,733 | -26,819 | -56,106 |
| Non-cash expenses related to equity purchase agreement | - | 0 | 1,190 | 667 |
| Depreciation, amortization, and accretion | 3,546 | 3,464 | 2,263 | - |
| Non-cash debt and financing costs | 802 | 503 | 1,302 | 1,380 |
| Depreciation and amortization | - | - | - | 778 |
| Loss on debt extinguishment | -5,191 | -120 | 0 | -1,412 |
| Non-cash interest income | 0 | 0 | 0 | 364 |
| Stock-based compensation | 7,053 | 8,302 | 10,151 | 18,260 |
| Loss on impairment and sale of long-lived assets | - | 0 | 0 | 0 |
| Provision for (benefit from) credit losses | 25 | 5,657 | -80 | 3,832 |
| Deferred income taxes | - | 1,588 | 5,561 | - |
| Change in fair value of financial instruments carried at fair value | -134 | - | 0 | - |
| Foreign exchange losses | -61 | -392 | -383 | -349 |
| Accounts receivable | -21,017 | 23,703 | -2,179 | -10,190 |
| Inventory | -14 | -6,664 | 6,695 | - |
| Contract assets | -2,902 | 12,669 | -177 | 931 |
| Prepaid expenses and other current assets | 2,987 | -1,887 | 1,015 | 1,944 |
| Advances to suppliers | 2,668 | 35,910 | -22,298 | -18,104 |
| Other assets | 2,578 | 1,151 | 2,555 | -717 |
| Accounts payable and accrued expenses | -67,698 | 35,428 | 27,871 | -3,296 |
| Contract liabilities | 8,594 | -56,350 | -2,522 | 56,072 |
| Customer deposit | 0 | - | - | - |
| Other long-term liabilities | -56 | 7 | -23 | -283 |
| Net cash used in operating activities | -53,797 | -6,570 | -11,708 | 12,629 |
| Purchase of intangible assets | - | 1,372 | - | - |
| Proceeds from sale of property and equipment | - | 0 | 0 | 0 |
| Purchase of property and equipment | 7,058 | 10,443 | 15,456 | 15,194 |
| Investment in note receivable | 0 | 0 | 0 | 2,142 |
| Investment tax credit proceeds | 11,765 | - | - | - |
| Net cash provided by (used in) investing activities | 4,707 | -11,815 | -15,456 | -17,336 |
| Proceeds from issuance of debt | 150,000 | 34,100 | 53,406 | 63,794 |
| Repayment of debt | 56,478 | 4,938 | 23,693 | 27,826 |
| Payment of debt issuance costs | 9,835 | 0 | 4,195 | 5,409 |
| Purchase of capped calls | 20,460 | - | - | - |
| Proceeds from insurance premium financings | 0 | 1 | 920 | 1,665 |
| Repayment of insurance premium financings | 343 | 845 | 834 | 1,225 |
| Proceeds from issuance of redeemable non-controlling interest | - | 33,679 | - | - |
| Payment of transaction costs related to redeemable non-controlling interest | - | 2,630 | - | - |
| Proceeds from issuance of stock | - | 0 | 5,650 | 1,199 |
| Short-swing profit recovery | 0 | 0 | 0 | 24 |
| Proceeds from exercise of stock options | 34 | 688 | 45 | 2 |
| Payment of finance lease obligations | 16 | 10 | 10 | 84 |
| Payment of taxes related to net settlement of equity awards | 1,749 | 424 | 0 | 0 |
| Net cash provided by financing activities | 61,153 | 59,621 | 31,289 | 32,140 |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 1,621 | 279 | -296 | 593 |
| Net increase in cash, cash equivalents, and restricted cash | 13,684 | 41,515 | 3,829 | 28,026 |
| Cash, cash equivalents, and restricted cash beginning of the period | 103,443 | 61,928 | 30,073 | - |
| Cash, cash equivalents, and restricted cash end of the period | 117,127 | 103,443 | 61,928 | - |
| Less restricted cash at end of period | 61,884 | 45,183 | - | - |
| Cash and cash equivalents - end of period | 55,243 | 58,260 | - | - |